It was reported that high levels of LDL receptor mRNA were associated with a decreased patient survival in pancreatic adenocarcinomas; high levels of LRP10 mRNA were associated with a decreased patient survival in hepatocellular carcinomas, lung adenocarcinomas, and pancreatic adenocarcinomas [60]. Here, LDLR is linked to pancreatic adenocarcinoma.